Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of vestibular paroxysmia with carbamazepine
DRKS00010942Phase 3Terminated
- Sponsor
- German Center for Vertigo and Balance Disorders
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carbamazepine in Vestibular Paroxysmia (VP) and Peripheral vertigo (2 arms), sponsored by German Center for Vertigo and Balance Disorders. Started Aug 2016; status: terminated.
02
Drugs
carbamazepine
03
Conditions
Vestibular Paroxysmia (VP)Peripheral vertigo
Beyond the preview
Go deeper on DRKS00010942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00010942.